Rx · PZN 17519077

MAVIRET 50 mg/20 mg coated granules in the sachets

German trade nameMAVIRET 50 mg-20 mg überzogenes Granulat im Beutel

Active ingredientGlecaprevir and pibrentasvirSubstance (DE)Glecaprevir und PibrentasvirPharmaceutical formGranules

Only sporadically available

1.3

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026

Highest known
purchase price (B2B)

~ €2,401

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is a rounded approximation. We are happy to advise you on your terms for MAVIRET 50 mg/20 mg coated granules in the sachets.

Review purchasing terms

MAVIRET 50 mg/20 mg coated granules in the sachets contains the active ingredient Glecaprevir and pibrentasvir (German Glecaprevir und Pibrentasvir) and comes as Granules. One pack size is recorded (PZN 17519077). The pharma availability index for German wholesale stands at 1.3 out of 10 over the past 30 days – the pack was therefore only sporadically available.

MAVIRET 50 mg/20 mg coated granules in the sachets was only sporadically procurable in the past 30 days. We help you identify additional sources of supply and alternative products.

Request a source of supply

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. One PZN is recorded for this product; the stated purchase price refers to it.